DEMERX, INC.
Fort Lauderdale, FL · Founded 2010 · CIK 0001489594 · Biotech · Private
Noribogaine hydrochloride, a novel psychoplastogen molecule for treating alcohol use disorder
demerx.com →- Grants
- $914K
- 1 award
- Sector median: 1
- Raised
- $290K
- 4 Form D · May 2015
- 137 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 21 granted · 19 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200920112013201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $85 | |
| Private capital raised | Form D · SEC | $15,000,000 | |
| Private capital raised | Form D · SEC | $8,250,000 | |
| Private capital raised | Form D · SEC | $289,569 | |
| Federal grant | Department of Health and Human Services · Phase I · Investigational New Drug Development of Noribogaine for Alcohol Use Disorder | $914,324 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1727 | Zyversa Therapeutics, Inc. | — | $3.6M |
| 1728 | PYROJAS INC | — | — |
| 1729 | Chicago Biosolutions, Inc. | — | — |
| 1730 | DEMERX, INC. | — | $290K |
| 1731 | Design Therapeutics, Inc. | — | $171M |
| 1732 | Halia Therapeutics, Inc. | — | $27M |
| 1733 | Iterum Therapeutics plc | — | $127M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Skip ClemmonsDirector
- Lawrence Friedhoff, M.D., Ph.D., FACPDirector · Executive Officer
- Steve GorlinDirector · Executive Officer
- Bruce HackDirector
- Maj. Gen. C. A. HenniesDirector
- Charles KoobDirector · Executive Officer
- E. KramerExecutive Officer
- Deborah MashDirector · Executive Officer
- Deborah Mash, Ph.D.Director · Executive Officer
- Henry MellonDirector
- Peter NejesDirector
- Steven Paul, M.D.Director
- Parker PetitDirector
- Franklyn Prendergast, M.D., Ph.D.Director
- Jeffrey RaneyExecutive Officer
- E. Burke Ross, Jr.Director
- Brian ThebaultDirector
- John Thomas, Jr.Executive Officer
- Holger WeisExecutive Officer
Patents
- Methods For The Non-toxic Treatment For Opioid Drug Withdrawal Combining Noribogaine And Cannabinoidsgranted
- Methods And Compositions For Reducing Tolerance To Opioid Analgesics Using Ibogaine And Derivatives Thereofapplication
- Methods And Compositions For Reducing Tolerance To Opioid Analgesics Using Ibogaine And Derivatives Thereofapplication
- Methods For Acute And Long-term Treatment Of Alcohol Dependence Using Ibogaine And Derivatives Thereofapplication
- Methods And Compositions For Potentiating The Action Of Opioid Analgesics Using Iboga Alkaloidsgranted
- Methods And Compositions For Potentiating The Action Of Opioid Analgesics Using Iboga Alkaloidsgranted
- Methods And Compositions For Reducing Tolerance To Opioid Analgesics Using Ibogaine And Derivatives Thereofapplication
- Noribogaine Compositionsapplication
- Methods And Compositions For Ibogaine Treatment Of Impulse Control Disorder, Anxiety-related Disorders, Violence And/or Anger, Or Regulating Food Intakegranted
- Methods For Acute And Long-term Treatment Of Alcohol Dependence Using Ibogaine And Derivatives Thereofapplication
- Methods And Compostions For Potentiating The Action Of Opioid Analgesics Using Iboga Alkaloidsgranted
- Methods For Acute And Long-term Treatment Of Alcohol Dependence Using Ibogaine And Derivatives Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.